Stock Analysis tagged as

Sector - Healthcare and Social Assistance

  • Showing 101-146 of 146 items
  • <<
  • 1
  • 2
  1. PPD Goes Private

  2. The 3 Highest Yielding Pharma Stocks

  3. MELA Gets A Surprising "Yes"

  4. Endo And Forest – Dumpster-Diving In Pharma

  5. R&D The Future For Life Sciences Equipment Firms

  6. When Times Are Tough, Should Investors Go Swiss?

  7. Medtronic's Healthy Growth Outlook

  8. Are Buybacks A Bad Sign?

  9. Betting On Healthcare's Growth Engine

  10. CVS Still Needs to Prove Itself

  11. BD Healthy, But No Great Bargain

  12. The Perpetual Boston Scientific Turnaround Story

  13. Teva And Mylan Show Some Value Remains In Generics

  14. Covidien's Image Starting To Change

  15. Top Dividend Stocks Owned By The Pros

  16. Top Healthcare Dividend Stocks

  17. Should Investors Circle Back To Cubist?

  18. Three Safe Sectors For The Summer

  19. Affymetrix's Downward Spiral Continues

  20. Should Biotech Investors Go Where Institutions Won't?

  21. Immucor Passes Its Last Test

  22. The Best IPOs From The First Half

  23. Top Drug Stocks

  24. Investing For Growth And Value

  25. Pleasure And Pain For Pfizer

  26. Johnson & Johnson Surrenders In Stents

  27. Lipitor: Pfizer's Loss Is Watson's Gain

  28. Should Investors Worry If Gen-Probe Doesn't Sell Out?

  29. 3 Reasons To Own Moog Inc.

  30. A Dull ASCO And The Usual Sell-Off

  31. Arena's New Data Doesn't Change Obesity Pill Outlook

  32. Medtronic Still Muddling Through

  33. Will Nestle Succeed Where Others Have Failed?

  34. Mergers In Orthopedics Could Heat Up Stocks

  35. Teva And Cephalon Solve Each Other's Problems

  36. 7 Dividend Stocks With Big Payouts

  37. Hologic Holding The Line

  38. Novo Nordisk Still One Of The Best Around

  39. Illumina Lights Up Again

  40. Despite The Noise, Abbott Still A Value

  41. J&J Beats Analyst Expections, But Not Its Rivals

  42. Can St. Jude Live Up To Newfound Expectations?

  43. GNC's Solid IPO

  44. Consolidation And Healthcare REITs

  45. Danaher Hopes To Revive Beckman Coulter

  46. Novartis Building Itself Into A One-Stop Shop

  47. MannKind And The FDA - Here We Go Again

  • Showing 101-146 of 146 items
  • <<
  • 1
  • 2
Trading Center